HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

COL1 C-propeptide cleavage site mutations cause high bone mass osteogenesis imperfecta.

Abstract
Osteogenesis imperfecta (OI) is most often caused by mutations in the type I procollagen genes (COL1A1/COL1A2). We identified two children with substitutions in the type I procollagen C-propeptide cleavage site, which disrupt a unique processing step in collagen maturation and define a novel phenotype within OI. The patients have mild OI caused by mutations in COL1A1 (Patient 1: p.Asp1219Asn) or COL1A2 (Patient 2: p.Ala1119Thr), respectively. Patient 1 L1-L4 DXA Z-score was +3.9 and pQCT vBMD was+3.1; Patient 2 had L1-L4 DXA Z-score of 0.0 and pQCT vBMD of -1.8. Patient BMD contrasts with radiographic osteopenia and histomorphometry without osteosclerosis. Mutant procollagen processing is impaired in pericellular and in vitro assays. Patient dermal collagen fibrils have irregular borders. Incorporation of pC-collagen into matrix leads to increased bone mineralization. FTIR imaging confirms elevated mineral/matrix ratios in both patients, along with increased collagen maturation in trabecular bone, compared to normal or OI controls. Bone mineralization density distribution revealed a marked shift toward increased mineralization density for both patients. Patient 1 has areas of higher and lower bone mineralization than controls; Patient 2's bone matrix has a mineral content exceeding even classical OI bone. These patients define a new phenotype of high BMD OI and demonstrate that procollagen C-propeptide cleavage is crucial to normal bone mineralization.
AuthorsKatarina Lindahl, Aileen M Barnes, Nadja Fratzl-Zelman, Michael P Whyte, Theresa E Hefferan, Elena Makareeva, Marina Brusel, Michael J Yaszemski, Carl-Johan Rubin, Andreas Kindmark, Paul Roschger, Klaus Klaushofer, William H McAlister, Steven Mumm, Sergey Leikin, Efrat Kessler, Adele L Boskey, Osten Ljunggren, Joan C Marini
JournalHuman mutation (Hum Mutat) Vol. 32 Issue 6 Pg. 598-609 (Jun 2011) ISSN: 1098-1004 [Electronic] United States
PMID21344539 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Copyright© 2011 Wiley-Liss, Inc.
Chemical References
  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Peptide Fragments
  • Procollagen
  • procollagen type I carboxy terminal peptide
Topics
  • Adolescent
  • Amino Acid Sequence
  • Animals
  • Bone Density (genetics)
  • Bone Matrix
  • Bone and Bones (abnormalities, pathology)
  • Calcification, Physiologic (genetics)
  • Child
  • Collagen Type I (genetics, metabolism)
  • Collagen Type I, alpha 1 Chain
  • Female
  • Humans
  • Male
  • Mice
  • Molecular Sequence Data
  • Mutation
  • Osteogenesis Imperfecta (genetics, pathology)
  • Peptide Fragments (genetics, metabolism)
  • Phenotype
  • Procollagen (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: